Ibrahim Khot
KHOTT BIOTECH
Dr Ibrahim Khot is an academic at the University of Bradford and Founder of KHOTT BIOTECH LTD, a health-technology company translating cutting-edge photodynamic therapy into next-generation wound-care market disrupting innovations. Bridging academia and enterprise, his work focuses on accelerating the clinical translation of therapeutic technologies, such as the PDPatch from bench to market. He earned his PhD in Medicine and Biology from the University of Leeds, followed by research fellowships at the University of Leeds and Kyoto University, funded by NIHR, UKRI, Wellcome, The Royal Society and Bowel Cancer UK. Ibrahim’s primary interest lies in springboarding innovation beyond the laboratory, transforming academic research into viable, impactful products. He has a strong track record of successful collaborations with scientists, clinicians and commercial partners to drive translational outcomes and real-world impact.
About the Enterprise
.png)
Chronic infected leg wounds are a silent epidemic, impacting over 2.2 million people in the UK and costing the global economy 15 billion USD. Underlying conditions such as diabetes, cardiovascular disease and immune disorders prevent healthy wound and current treatments fail to control infection or stimulate healing effectively and antibiotics overreliance drives antimicrobial resistance.
​
PDPatch is a revolutionary wound dressing, harnessing the active therapeutic properties of photodynamic therapy (PDT) to eradicate bacteria and accelerate tissue regeneration, without antibiotics. PDPatch integrates our photosensitiser-delivering PhotOxy Gel with specialised LED fibre optics providing on-demand therapy.
​
Designed for both hospitals and home care, PDPatch simplifies treatment and reduces healthcare costs.
Over the next decade, PDPatch aims to transform global wound care by delivering safe, accessible and antibiotic-free healing, revolutionising wound care.
Achievements
& Highlights
-
Secured clinical partnerships with Leeds NHS, NHS Tayside and Victoria Mxenge Hospital (Durban, South Africa) that will serve as clinical evaluation sites.
​
-
Winner of the Plug and Play 2025 Entrepreneurs Next Star & Million Prize Global Challenge; invited to join Plug and Play Playbook and working with Tencent to explore China and ASEAN markets.
​
-
Successfully secured £200,000 in non-dilutive funding from NIHR i4i THRIVE and EPSRC Impact Accelerator and part of the NIHR healthcare technologies entrepreneurs programme.
Contact
Got an idea, question, or collaboration in mind? Let’s connect.
